BIT 2.22% 4.6¢ biotron limited

Ann: Lead Series for SARS-COV-2 Program, page-116

  1. 5,587 Posts.
    lightbulb Created with Sketch. 657
    Big Pharma don’t have time for micro biotechs when it’s cheaper to do everything in-house these days with the tech that they have at their disposal

    BIT have to send all n sundry to third parties to generate results

    These third parties have a huge backlog of tests and demand premium prices

    meanwhile big pharma produce the commercial goods
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $41.50M
Open High Low Value Volume
4.4¢ 4.7¢ 4.4¢ $31.64K 708.3K

Buyers (Bids)

No. Vol. Price($)
4 259000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 17361 1
View Market Depth
Last trade - 14.10pm 21/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.